Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
RP3-340N1.2 Knockdown Restricts NSCLC Progression via IL-6 D
2026-04-13
This study identifies RP3-340N1.2 as a key long non-coding RNA upregulated in non-small cell lung cancer (NSCLC), driving malignant progression by stabilizing IL-6 mRNA. Knockdown of RP3-340N1.2 leads to suppressed tumor cell proliferation and migration, highlighting a potential molecular target for therapeutics and providing a mechanistic framework for RNA metabolism studies.
-
GSK343 EZH2 Inhibitor: Protocols and Innovations for Epigene
2026-04-13
GSK343 is transforming epigenetic cancer research by enabling precise, reproducible inhibition of EZH2-mediated H3K27 trimethylation in vitro. This guide translates recent mechanistic breakthroughs—including the role of APEX2 in TERT regulation—into actionable workflows, troubleshooting strategies, and protocol optimizations for cancer and stem cell researchers.
-
Hematoxylin and Eosin Staining Kit: Protocols and QC Guide
2026-04-12
The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides ready-to-use reagents for consistent visualization of tissue morphology in paraffin-embedded and frozen sections. It streamlines workflow for histopathological and cytological analysis, but is not intended for clinical diagnostics or applications outside research environments.
-
Otilonium Bromide: Bridging Cholinergic Modulation to Transl
2026-04-12
Explore how Otilonium Bromide, a high-purity antimuscarinic agent, empowers translational researchers to dissect cholinergic signaling pathways, model gastrointestinal motility disorders, and advance neuroscience. This thought-leadership article integrates mechanistic insights, protocol guidance, and strategic vision, building on the latest literature and contextualizing its unique value in experimental and translational pharmacology.
-
Alcian Blue & Nuclear Fast Red Staining Kit: Precision in Ch
2026-04-11
The Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5, empowers researchers with streamlined, dual-color identification of acid mucopolysaccharides and cellular nuclei. Optimized for chondrogenic differentiation and mucin detection, this kit simplifies workflows and enhances morphological clarity in tissue and stem cell assays.
-
EPZ5676: High-Precision DOT1L Inhibitor for Leukemia Researc
2026-04-11
EPZ5676 sets a new benchmark as a potent and selective DOT1L inhibitor, enabling robust H3K79 methylation inhibition and targeted MLL-rearranged leukemia research. This guide focuses on experimental workflows, practical optimizations, and troubleshooting strategies to maximize data quality in epigenetic assays.
-
Abscisic acid (Dormin): Use Guidelines for Plant Stress Rese
2026-04-10
Abscisic acid (Dormin) is a specialized plant hormone used to study seed dormancy, germination, and abiotic stress responses. This product is best applied in plant biology workflows that require precise modulation of physiological or epigenetic processes, particularly where water-insoluble compounds are manageable. It is not suitable for workflows that require aqueous solubility or long-term storage of working solutions.
-
Hematoxylin and Eosin Staining Kit: Reliable Tissue Morph...
2026-04-10
This article provides evidence-based, scenario-driven guidance for biomedical researchers and lab personnel using the Hematoxylin and Eosin Staining Kit (SKU K1142). Drawing from real laboratory challenges and recent literature, we explore how this ready-to-use solution from APExBIO enables reproducible, high-contrast tissue morphology visualization, underscoring its value in histopathology and cytological analyses.
-
Reversine: Advanced Insights into Aurora Kinase Inhibitio...
2026-04-09
Explore the multifaceted role of Reversine, a potent Aurora kinase inhibitor, in cancer cell proliferation inhibition and developmental model systems. This in-depth article uniquely integrates mechanistic analysis, state-of-the-art gastruloid research, and practical guidance for advanced cancer research.
-
Trichostatin A (TSA): Data-Driven Optimization for Epigen...
2026-04-08
This article provides a scenario-based, evidence-driven exploration of Trichostatin A (TSA) (SKU A8183) for biomedical researchers. It addresses experimental design, protocol optimization, data interpretation, and product reliability, highlighting how APExBIO's TSA enables robust, reproducible results in cell viability, proliferation, and epigenetic assays. All guidance is grounded in primary literature and validated use cases.
-
Reversine (SKU A3760): Reliable Aurora Kinase Inhibition ...
2026-04-08
This article provides a scenario-driven, evidence-based overview of Reversine (SKU A3760) for biomedical researchers tackling challenges in cell viability, proliferation, and cytotoxicity assays. It highlights how Reversine’s nanomolar potency, compatibility with standard workflows, and validated supplier reliability from APExBIO deliver reproducible results for advanced cancer research.
-
Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5: Advan...
2026-04-07
Discover advanced methodologies using the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5, for precise acid mucin detection and chondrogenic differentiation analysis. This article delivers a unique, evidence-based perspective on quantitative histological staining and workflow optimization.
-
Redefining the Epigenetic Frontier: Strategic Guidance fo...
2026-04-07
This thought-leadership article explores the paradigm shift in epigenetic cancer research driven by selective histone acetyltransferase inhibitors such as WM-8014. Blending mechanistic insight with actionable strategy, it covers the biological rationale for targeting the MYST acetyltransferase family, experimental validation in oncogene-induced senescence models, the evolving competitive landscape, and translational implications for cancer biology. The article distinguishes itself from conventional product resources by integrating recent CRISPR screening evidence and providing a roadmap for next-generation workflows—positioning WM-8014 as a cornerstone for precision epigenetic research.
-
Trichostatin A (TSA): Unveiling New Frontiers in Epigenet...
2026-04-06
Explore the multifaceted role of Trichostatin A, a potent histone deacetylase inhibitor, in advanced epigenetic research and regenerative biology. This in-depth analysis reveals novel mechanisms, translational opportunities, and distinct applications for TSA in cancer and limb regeneration models.
-
Cl-Amidine trifluoroacetate salt: PAD4 Inhibitor in Epige...
2026-04-06
Explore the advanced applications of Cl-Amidine trifluoroacetate salt as a potent PAD4 deimination activity inhibitor. This article delves into its mechanistic role in epigenetic regulation and its translational value in cancer, rheumatoid arthritis, and septic shock research—offering new insights beyond standard protocol guides.